Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives

The prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) has increased among the general population and chronic hepatitis B (CHB) patients worldwide. Although fatty liver disease is a well-known risk factor for adverse liver outcomes like cirrhosis and hepatocellular carcinoma,...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shang-Chin, Liu, Chun-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121303/
https://www.ncbi.nlm.nih.gov/pubmed/36726053
http://dx.doi.org/10.3350/cmh.2022.0422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121303/
https://www.ncbi.nlm.nih.gov/pubmed/36726053
http://dx.doi.org/10.3350/cmh.2022.0422

Ejemplares similares